Innate Pharma S.a. buy metanicnor
Start price
12.01.20
/
50%
€6.00
Target price
04.11.21
€30.00
Performance (%)
-29.67%
End price
22.11.20
€4.22
Summary
This prediction ended on 22.11.20 with a price of €4.22. The price of Innate Pharma S.a. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -29.67%. metanicnor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innate Pharma S.a. | - | - | - | - |
| iShares Core DAX® | -0,38 % | 2,61 % | 11,34 % | 61,27 % |
| iShares Nasdaq 100 | -0,41 % | -2,00 % | 5,35 % | 90,63 % |
| iShares Nikkei 225® | 1,84 % | 9,39 % | 33,53 % | 67,98 % |
| iShares S&P 500 | -0,71 % | -0,48 % | 2,51 % | 62,52 % |
Comments by metanicnor for this prediction
In the thread Innate Pharma S.a. diskutieren
Buy with target price 30.0


